Researchers will develop and validate a novel molecular tool to assess residual cancer cell levels in dogs with aggressive T-cell lymphoma to help improve treatment and disease monitoring.
Researchers will collect and analyze lung tissue from dogs enrolled in a clinical trial for bone cancer that has spread to the lungs in hopes of discovering new ways to treat this common and aggressive canine cancer.